KIMBERLY CAMPBELL: Open Payments
NPI 1093945222 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 24 payments from 10 companies in 2025. Trend: 2023 $631 · 2024 $683 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $129 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Boston Scientific Corporation | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Abbott Laboratories | 2 | $47 |
| Amgen Inc. | 2 | $35 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: ELIQUIS, LEQVIO, WATCHMAN FLX, CAMZYOS, Kerendia, MITRACLIP, REPATHA, LifeVest.
Industry payments across IN — which companies pay providers there.
